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Abstract 
 
The critical role of migration and invasion in cancer metastasis warrants new 
therapeutic approaches targeting the machinery regulating cell migration and 
invasion. While 2-dimensional (2D) models have helped identify a range of adhesion 
molecules, cytoskeletal components and regulators that are potentially important for 
cell migration, the use of models that better mimic the 3-dimensional (3D) 
environment has yielded new insights into the physiology of cell movement. For 
example, studying cells in 3D models has revealed that invading cancer cells may 
switch between heterogeneous invasion modes and thus evade pharmacological 
inhibition of invasion. Here we summarize published data in which the role of cell 
adhesion molecules in 2D versus 3D migration have been directly compared, and 
discuss mechanisms that regulate migration speed and persistence in 2D and 3D.  
Finally we discuss limits of 3D culture models to recapitulate the in vivo situation. 
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Introduction 
 
Nearly all adherent cells are able to crawl and migrate under standard 2D cell culture 
conditions.  Time-lapse recordings of migrating cells never fail to excite a sense of 
awe about the complexity of the migration process, as lamellipodia and filopodia 
form, extend and make contact with the matrix, as cells change their shape, lunge 
forward, contract and detach. Cell migration depends on a variety of temporally and 
spatially orchestrated parameters, with several hundreds of proteins involved.  
Although changes in cell migration after knock-out or mutation of a protein may not 
be the ultimate proof of a causal relationship; watching cells migrate and measuring 
parameters of cell speed and directional persistence have proven invaluable in 
elucidating the functional components regulating intrinsic cell migration in 2D. A 
number of studies have now begun to examine these same parameters using 3D 
culture systems.  
 
Interstitial dissemination 
The ability of cancer cells to invade tissue surrounding the primary tumour site, 
leading to the development of metastatic tumours, is one of the hallmarks of cancer.1 
Disseminating tumour cells encounter a variety of tissue architectures through which 
they must transmigrate. While the majority of tumour cells are confronted by 
collagen-rich connective tissue found around most organs in the body, invasion in the 
brain represents a specialized form of transmigration due to the unique makeup of the 
brain interstitium. For more detail we direct readers to an excellent, recent review that 
provides a comprehensive description of tissue structures through which cancer cells 
transmigrate in vivo.2 The structure and composition of the interstitial tissues 
determines the mechanisms that must be employed by the cancer cells for successful 
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navigation. Gritsenko and colleagues2 suggest three generic mechanisms employed by 
invasive cancer cells: contact guidance along stiff matrix elements through integrin 
mediated mechanisms, directed migration towards chemokines and growth factors, 
and physical pushing through small spaces.  
 
Cell migration in vivo 
The process of cell migration and invasion is, of course, not restricted to metastatic 
cancer. Cell migration and invasion occurs during embryonic development and 
continues throughout adulthood as it is critical for the correct execution of a variety of 
biological programs. During embryonic development there are precise migration and 
invasion events that are necessary for the final correct organization of the adult tissue. 
A particularly well-studied example of this is during the development of the 
mammalian brain, where cells undergo precisely timed migration events that are 
essential for the final tissue organization and wiring of the fully developed brain (for 
review see ref 3). The migration speed and persistence of distinct cell populations 
appear to be important parameters for determining their final destination in the 
maturing brain tissue. Moreover, cell populations change speed as they migrate 
throughout different zones of the brain.4 Mutations which alter speed and directional 
persistence of migrating neuronal cell populations can therefore perturb the 
organization of the brain tissue into discrete layers.5, 6 
 
The consequences for changes in speed and persistence of invasive cancer cells are 
currently less well known.  Approaches that abrogate cell movement in environments 
that mimic the tissue organization of the in vivo tumour are generally considered to be 
strong candidates for novel therapies to treat metastatic cancer. Similarly, approaches 
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that do not completely abrogate movement but instead slow down the rate of cell 
migration are expected to restrict the dissemination of cells from the primary tumour 
and increase the window of opportunity for localized and targeted delivery of 
therapies. In the particular case of highly invasive primary brain tumours such as the 
deadly grade IV gliomas (also known as glioblastoma), there is extensive collateral 
damage to the brain tissue as a result of the invading tumour cells, leading to 
significant loss of quality of life.7 Thus, even a partial reduction of tumour invasion 
may ameliorate some of the collateral damage that occurs in the brains of these 
patients. Moreover, targeting the cell’s migration machinery may in turn sensitize the 
cells to different therapies. One example of such sensitization is tumour cells lacking 
expression of the invasion/metastasis promoter NEDD9. These cells appear to 
concomitantly become sensitized to the effects of Src kinase inhibition.8 Similarly, 
decreasing the persistence of the cancer cell movement will necessarily decrease the 
numbers of successful escapers from the primary tumour site. But to confirm these 
speculations and expectations, any anti-invasive therapy must first demonstrate its 
effectiveness in models that mimic the natural in vivo 3D organization of the relevant 
tissue surrounding a particular tumour. 
 
3D culture models 
The interactions between cells and the external environment, either with the ECM or 
with neighbouring cells, are in a literal sense vitally important. Once thought to solely 
provide physical and structural support, the ECM is now known to regulate and 
influence survival,9 proliferation,9 migration and adhesion,10, 11 morphology,12 internal 
cellular structures,13 and signalling pathways.11 During tumorigenesis, cellular 
interaction with the ECM can become deregulated not only as a result of altered 
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integrin and focal adhesion protein expression, but also because tumour cells can 
rearrange the local native tissue architecture, alter its chemical composition, structure 
and stiffness, which in turn often promotes cell migration and invasion.14, 15 For 
example, in breast carcinomas the formation of the distinctive palpable ‘lump’, known 
as demosplasia, is attributed to tumour cell secretion of platelet derived growth factor 
(PDGF). This induces the deposition of large quantities of collagen and collagen 
cross-linkers by surrounding fibroblasts, thus increasing local tissue stiffness and 
rigidity.16, 17  
 
In vivo, most invading cancer cells encounter two major ECM groups. The first is the 
basement membrane that directly interacts with both the epithelium and endothelium 
layers. The second is the interstitial matrix.  It harbours numerous collagen isoforms 
and fibronectin and is thought to contribute to the overall mechanical strength of the 
tissue. In vitro, the extracellular matrix is most commonly planar, tissue-culture 
treated plastic, or sometimes glass coated with collagen, fibronectin or other ECM-
derived proteins. Even then, comparative analysis of cell migration and morphology 
has revealed striking inconsistencies between cells grown on 2D surfaces versus those 
seeded within 3D matrices.13, 18 Therefore, in attempting to recreate a cell’s in vivo 
environment, it is not sufficient to only consider which ECM group the cell type in 
question is most likely to interact with; it is equally important that the 3D structure 
and mechanical properties of the matrix closely mirror that of the in vivo 
environment. Three of the most commonly used in vitro 3D matrix models - fibrous 
gels, basement membrane extracts (or Matrigel), and cell-derived matrices - are 
discussed in the following sections.  
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Fibrous gels 
Fibrous gels, namely reconstituted collagen and fibrin gels, aim to replicate the major 
architectural and structural components of the extracellular matrix. Collagen and 
fibrin emerged as ideal candidates for single-protein 3D matrix models as both are 
major structural components of the extracellular matrix. It is worth noting, however, 
that interstitial tissue is composed of heterogenous mixtures of ECM components, 
which these gels do not recapitulate.19 Nevertheless, due to the abundance of collagen 
and fibrin in vivo, reconstituted fibrous gels are physiologically compatible with 
numerous cells types. Fibrin gels are particularly suitable to study migratory events 
involved in wound healing,20, 21 while collagen gels are more suitable to study 
interstitial cell migration and metastatic invasion.10, 22, 23  
Not all fibrous gels are created alike however. Seemingly minor protocol variations 
can have major effects on the gel properties. For instance, an increase in fibre 
concentration enhances fibre density,24, 25 resulting in an overall increase in the 
mechanical strength of the gel.26 Additionally, the effective pore size of the fibrous 
meshwork decreases at higher fibre concentrations,27 thus increasing steric hindrance 
for migrating cells.28, 29 The gelation temperature will also affect the mechanical and 
structural details of the gel; for instance, the pore size and fibril diameter decreases 
and the number of fibrils formed increases at higher polymerization temperatures.27, 30  
 
The production details of harvesting, dissolving and purifying collagen or fibrin from 
different animal tissues are also a source of substantial variability. This is especially 
true in the case of collagen, where fibres harvested e.g. from bovine Achilles tendon 
demonstrate a higher denaturation temperature and a thicker fibre diameter when 
compared to collagen harvested from rat tail tendon.31,27, 32 The method for dissolving 
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the collagen, whether with acid or by proteolytic digestion (i.e. pepsin or trypsin) 
similarly influences the structure and polymerization kinetics of the reconstituted gels. 
Acid-dissolved collagen will begin the fibrillogenesis process more rapidly,31, 33, 34 
showing characteristic fibre lengths and diameters that closely resemble those 
observed in vivo.35 In comparison, collagen extracted by proteolytic enzyme digestion 
shows significantly smaller fibre diameters and reduced fibril formation, thus 
reducing the gels’ strength and rigidity.30, 31, 36 
Basement membrane extracts 
Matrigel is a reconstituted basement membrane matrix product extracted from 
Engelbreth-Holm-Swarm (EHS) mouse sarcoma cells. When polymerized, Matrigel 
mimics the microenvironment of in vivo extra-cellular basement membrane.37-39 
Composed chiefly of laminin, collagen IV isoforms and heparan sulphate 
proteoglycans, basement membranes provide a unique signalling platform for cells 
that adhere to it. 40, 41  Matrigel 3D substrates can restore the normal morphological 
characteristics and specific cell functions that would otherwise be lost under standard 
cell culture conditions, especially in epithelial-,42, 43 endothelial-,44 and Schwan-
derived cells.45 But this is not generally true for all cells; for instance fibroblasts that 
are not normally in contact with a basement membrane in vivo adopt a noticeably 
uncharacteristic rounded morphology and exhibit a non-migratory phenotype when 
cultured in Matrigel.12, 39  
Cell-derived matrix 
When cultured at high density, fibroblasts “bioengineer” their own extracellular 
matrix.46 This cell-derived matrix (CDM) is composed of fibronectin,47 collagen types 
I and II,48 hyaluronic acid49 and heparin sulphate proteoglycans.49, 50 CDMs mirror the 
flexibility and malleability of an in vivo ECM, as cells seeded onto a CDM can 
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reorganise and modulate the matrix, recapitulating the migration and invasion events 
of both physiological and metastatic processes observed in vivo.11, 12, 51 However, as 
with all protocols, there are limitations to this method also.  Somewhat problematic is 
the poorly defined and highly variable composition of fibroblastic CDMs. Moreover, 
although CDMs display a 3D matrix organization, these matrices are typically thin 
and therefore subject to the rigidity of the underlying 2D surface. Regardless, the use 
of CDM has permitted insights into the signalling pathways that govern proliferation, 
morphology, cell-matrix attachments and individual cell migration, all of which 
impact and promote tumorigenesis.11, 12, 51  
 
Cell adhesion  
The role of focal adhesions has been thoroughly studied in 2D cultures and has 
provided important insight into the mechanisms of cell movement in 2D. However, as 
investigators have turned to the analysis of focal adhesions in 3D, there has been 
conflicting reports regarding their presence and detection in 3D.12, 52, 53 We direct 
readers to the excellent review by Harunaga54 for a comprehensive analysis of the 
issue of cell-ECM adhesions in 3D culture models. The upshot of which is that focal 
adhesions do exist in 3D, but the composition, mechanical properties and structure of 
the 3D matrix profoundly affects the appearance and distribution of focal adhesions.12  
 
In Table 1 we summarize data from studies in which migration parameters of speed 
and persistence have been directly compared between 2D and 3D culture conditions 
in the same cell background. Treatments that are expected to promote invasion and 
metastasis in vivo such as stimulation with EGF, complete oncogenic transformation 
following combined expression of ErbB2 and 14-3-3ζ and high α5β1 expression all 
promoted faster migration speed in 3D cultures, yet had variable effects in 2D (Table 
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1). For example, breast epithelial cells induced to undergo oncogenic transformation 
displayed reduced migration speed in 2D,55 while EGF treatment of glioblastoma cells 
increased 2D speed.56 Similarly, cells from a metastatic progression series showed 
increasing speeds in 3D collagen gels, but decreasing speeds in 2D.57 Without 
exception, the knock-down or loss of cytoplasmic members of focal adhesion sites 
(p130Cas, NEDD9, vinculin, talin, FAK, VASP, paxillin and Hic-5) inhibited cell 
migration speed in 3D cultures, yet again varied results are seen in 2D cultures. 
Depletion of these molecules variously increased 2D speed (p130Cas, NEDD9, 
vinculin knockout fibroblasts), decreased 2D speed (talin, FAK) or did not alter speed 
relative to controls (vinculin shRNA in HT1080 fibroblasts, VASP). With the 
exception of EGF stimulation and high α5β1 expression, all treatments resulted in 
reduced intrinsic persistence of migration in 3D. As was seen for the speed data, there 
is no clear correlation between effects on migration persistence in 2D and effects seen 
in 3D. 
Forces in cell migration 
The disparate results for 2D and 3D speed and persistence in exactly the same cell 
background highlight critical differences between these different model systems. Cell 
migration in 2D differs in one fundamental aspect from 3D migration in that steric 
hindrance is absent. In 2D, the cell needs to overcome only the frictional (drag) forces 
form the surrounding liquid and the 2D surface.  At a speed of only a few microns per 
minute, liquid drag can be neglected, as the force of a single myosin motor would be 
sufficient to propel the cell forward. Thus, the better a cell adheres to its substrate, the 
greater the contractile force needed to overcome the adhesive friction from cell-matrix 
adhesions; as a general rule, a cell with poorer adhesion can migrate faster on a 2D 
surface. Poorer adhesion can either be a consequence of a lower matrix protein 
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density on the surface,58 or a consequence of a reduced expression level of adhesion 
proteins on the cell (for examples, see Table 1). Of course, a minimum amount of 
adhesion is essential for cell movement as otherwise the cell cannot polarize or 
activate its contractile machinery.58 Thus, in a 2D context, changes in focal adhesion 
dynamics59, 60 dominantly effect cell migration speed and likely explain the disparate 
effects on 2D cell migration seen following depletion of focal adhesion-associated 
molecules (Table 1).  
 
 
In 3D, in addition to frictional forces, the cell also has to overcome forces that arise 
from the steric hindrance of the matrix network, provided that the pores and crevices 
through which the cell migrates are smaller than the cell itself. Here, the cell has two 
options. It can either deform itself until it can fit through the pores; or it can deform 
the network until the pores are large enough for passage. Switching between cell body 
deforming versus matrix deforming migration strategies is evidenced by changes in 
cell morphology from rounded cell shapes to elongated cell shapes.61 Deforming the 
cell body sufficiently to squeeze through small pores requires forces for overcoming 
the elastic and frictional forces of the cytoskeleton. The cell can decrease cytoskeletal 
elasticity (stiffness) and friction by depolymerizing cytoskeletal filaments, but 
although this would reduce the forces necessary to deform the cell until it fits through 
a pore, it also reduces the force-generating capacity of the acto-myosin contractile 
apparatus.  
 
Analogously, deforming the matrix network requires forces for overcoming the elastic 
and frictional forces of the matrix. By secreting matrix-digesting enzymes, the cell 
can soften the network structure or increase its porosity, thereby reducing the 
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necessary forces for deforming the matrix network until the cell can fit through.  But 
at the same time this also limits the ability of the cell to adhere to the matrix, which is 
a prerequisite for contractile force generation. Therefore, does the speed of intrinsic 
cell migration in 3D give clues as to whether cells are using the rounded (cell body 
deforming) versus elongated (matrix deforming) cell migration strategies? Initial 
descriptions suggested that there is no loss of cell speed between the two modes.10 
However, absolute cell speed depends on the make-up of the surrounding matrix. 
While partial transformation of breast epithelial cells (Erb2 or 14-3-3ζ 
overexpression) did not affect cell speed in “compliant” collagen gels (103Pa elastic 
modulus), cells had reduced migration speed in “stiff” collagen gels (391Pa elastic 
modulus).55 Similarly, increasing steric hindrance at high collagen concentrations can 
inhibit cell invasion.62 Thus the concentration of the matrix, extent of cross-linking 
and matrix pore size all critically determine cell speed and moreover, whether a 
matrix deforming or cell body deforming mode of invasion is possible. Given the 
ultimate goal of determining the molecular mechanisms that promote cancer cell 
invasion and metastasis, it will be increasingly important to adopt a range of 3D 
culture models that can mimic the various different extra-cellular environments 
encountered by invading cancer cells in vivo. Two examples from recent studies with 
opposing findings highlight the problem in interpreting data that are measured under 
only a single condition: Several studies have reported that invasive, metastatic cancer 
cells are softer than their nonmetastatic counterparts derived from the same tissue63, 64 
when measured under non-adherent conditions.  By contrast, in adherent cancer cells, 
the opposite behaviour is seen, with more invasive cells tending to be more contractile 
and consequently stiffer.65, 66   
 
 14
Predictive power of 3D invasion models for cancer metastasis. 
The goal of the 3D cell migration models is to better mimic the physiological 
environment. An important question in cancer research therefore is how successfully 
data from the 3D models predicts in vivo metastatic behaviour. To address this 
question we have searched the literature for examples where adhesion molecules that 
have been directly compared in 2D versus 3D models (Table 1) have been analysed 
using in vivo models of metastasis and invasion (Table 2). There is an extensive 
literature on mouse models of cancer cell invasion, but for our purposes we have 
limited our analysis to studies where adhesion molecules from Table 1 have been 
manipulated by overexpression or knockdown. It is noticeable that surprisingly few 
studies have been carried out to directly test the effects of these molecules on in vivo 
tumour invasion and metastasis – the bulk of studies have focused on tumour 
initiation. Our search yielded examples for FAK, p130Cas, NEDD9, vinculin, talin, 
β1 integrin and α5β1 and αvβ3 integrin receptors (Table 2).  
 
The in vivo models used in the summarized studies can be divided into three 
categories: (1) tissue specific neo-oncogenesis that recapitulates carcinoma 
progression seen in human disease67-72 and orthotopic injection: both have the 
advantage of mimicking the correct tissue context of the human disease;73-77 (2) sub-
cutaneous injection at non-orthotopic sites;78-80 and (3) intravenous  injection.8, 81-85 In 
the case of the first two categories successful metastasis requires the tumour cells to 
invade locally, intravasate into blood or lymph vessels, extravasate at secondary sites 
and form new tumours. Conversely, intravenous injection does not depend on the 
formation of a primary tumour, thus allowing separation of the effects of primary 
tumour formation from dissemination into secondary tissues. This approach is 
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frequently used when the molecule or pathway of interest inhibits initial tumour 
formation. A limitation is that this does not address initial migration and invasion 
away from primary tumour sites. A further important caveat to all of these models is 
that none measure migration and invasion alone. The ability of the tumour cells to 
disseminate and form secondary tumours is a multifactorial process, which 
additionally requires survival in the circulation, adhesion to vessel endothelial layers, 
and transmigration through the endothelium. Below we compare data for 3D 
migration speed and persistence with in vivo metastasis results in response to altered 
adhesion molecule expression and activities. 
 
FAK, p130Cas, talin and vinculin 
To date, a large number of studies have focused on the role of FAK for in vivo 
metastasis. FAK has long been known to be up-regulated in a wide variety of invasive 
cancer types (reviewed in ref 86). Cancer cells in which FAK is either homozygously 
deleted or down-regulated via expression of a dominant negative form of FAK 
universally display reduced metastatic tumour formation (Table 2), matching the 
findings that FAK depletion reduces 3D cell migration speed (Table 1). FAK 
depletion inhibited metastatic tumour formation in all three categories of in vivo 
invasion models (see above). Congruent results were also seen between 3D culture 
migration speed and in vivo metastases for p130Cas and talin (Tables 1 and 2). 
However, the data are not so clear for vinculin. The depletion or absence of vinculin 
had no effect52 or led to reduced migration speed87 in 3D models. In contrast, a high 
level of exogenous vinculin expression reduced lung tumour formation in vivo.80 
 
NEDD9 
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NEDD9 overexpression promotes invasion and metastasis in a range of cancer cell 
types88. In apparent concordance with this, NEDD9 depletion reduces fibroblast 
migration in 3D collagen gels (Table 1). However, while NEDD9-/- tumour cells in a 
model of oncogenic transformation of mammary epithelia had a tendency to form 
fewer metastatic tumours,67 tail vein injection of these isolated cells revealed 
aggressive lung tumour formation.8 Potentially, this may represent a switch to the 
amoeboid/cell deforming invasion mode that occurs following NEDD9 depletion22 
which may promote lung colonization. By contrast, the dense, rigid matrix that is 
reported to characteristically surround breast tumours,89 which is presumably present 
in the transformed breast epithelia model, may obviate the rounded/cell deforming 
mode of invasion. Alternatively, increased metastatic lesions following tail vein 
injection may reflect changes in survival in circulation, adhesion and transmigration 
of the endothelial cell layer of the vessel.  
 
β1 integrin 
The effects of β1 integrin depletion on migration in Matrigel are dependent on the 
Matrigel concentration; at high concentrations when the gel is less deformable, the 
loss of β1 impaired the ability of the cells to invade.90 These results are in agreement 
with in vivo data where β1 depletion also caused reduced metastatic lesions (Table 2). 
In one of the studies, increased numbers of tumour emboli in the lymphatic 
vasculature were noted68. This suggests that the cells in this model were competent to 
locally invade and intravasate, but were not able to execute the final stages required 
for secondary tumour formation.  
 
α5β1 and αvβ3 integrin receptors 
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The finding that high level α5β1 is associated with enhanced migration speed and 
persistence of breast cancer cells in 3D collagen gels62 appears to agree with reports 
that α5 depletion reduced lung colonization in a tail vein injection model.83 However, 
when α5 and β1 are analysed separately, the findings are conflicting. Exogenous α5 
expression was shown to significantly reduce lung and extrapulmonary metastases 
arising from injected colon cancer cells85. Upregulation of β3 expression increased 
bone and lung metastases,76, 81 yet decreased lung tumour formation in an invasive 
melanoma model.91 Fibroblasts lacking β3 integrin expression have significantly 
faster migration speeds and reduced migration persistence in a 3D CDM assay 59. It is 
difficult to estimate to what degree the usage of different cell types has contributed to 
the disparate findings. For instance, the differential expression of other integrin 
receptors in different cell types may have influenced the invasion and metastasis 
behaviour. In particular, it has been suggested that cross-talk between recycling α5β1 
and αVβ3 receptors may be an important mechanism of regulating migration 
persistence.92 These data highlight the need for direct comparison between 3D culture 
models and in vivo metastasis models for validation.  
 
CONCLUSION 
Our comparison of the effects of a handful of studies that have investigated adhesion 
proteins in 2D versus 3D culture models with in vivo measurements of metastasis has 
revealed a complex picture. For instance, it is notable that without exception, the 
depletion of the adhesion molecules summarized in Table 1 resulted in decreased 
migration persistence in 3D models but not always in reduced metastasis formation in 
vivo (Table 2). To accurately predict in vivo invasion behaviour, we need 3D model 
systems are required that faithfully replicate the physical characteristics of the 
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environments encountered by transmigrating cancer cells. In particular it will be 
critical to develop model systems mimicking the interstitial tissue organization both at 
the primary tumour site and at the metastatic niches that characterize different 
tumours. Such tailored 3D models to map the journey taken by metastasizing cancer 
cells are still lacking for interactions with the vasculature, host immune responses and 
other cell-cell interactions, and can generally mimic only short-term (< 1 week) 
conditions (Yamada & Cukierman Cell 2007). But even with these limitations, 3D 
models are essential for gaining a basic understanding of cell migration and invasion 
through tissue and will ultimately lead to novel cancer therapies.  Invasion away from 
the primary tumour site fundamentally underpins metastatic progression, and 
treatments that target invasion therefore hold the promise of significantly improving 
survival rates for most cancers. 
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Adhesion 
Molecule  
 
Cell Line 
2D 3D 
Speed Persistence Speed Persistence 
p130Cas 
shRNA52 
HT1080  
fibrosarcoma ↑ ↑ 3D collagen ↓ ↓ 
NEDD9 
knockout(b)60 Fibroblast ↑  ND 3D collagen ↓ ↓ 
Vinculin 
knockout87 Fibroblast ↑ ↑ 3D collagen        ↓  ND 
Vinculin 
shRNA52 
HT1080  
fibrosarcoma = = 
3D collagen 
No change ↓ 
β3 integrin 
knockout(a)59 Fibroblast ↑ ↓ CDM
# 
↑ ↓ 
EGF 
stimulation56 
U87MG  
glioblastoma ↑ ↓ 3D collagen
e 
↑ 
3D collagen 
↑ 
β1 integrin 
inhibition52 
DU-145  
prostate 
cancer 
Biphasic ND 
Low Matrigel 
%:  
↑ 
High Matrigel 
%:  
↓ 
ND 
Talin shRNA52 HT1080  fibrosarcoma ↓ ↑ 3D collagen ↓ ↓ 
FAK shRNA52 HT1080  fibrosarcoma ↓ ↑ 3D collagen ↓ ↓ 
VASP shRNA52 HT1080  fibrosarcoma = = 
3D collagen 
↓ ↓ 
Transformation  
progression  
series:55 
(1) + ErbB2  
(2) + 14-3-3ζ 
(3) +ErbB2+14-
3-3ζ  
 
MCF10a 
non-
transformed 
breast 
epithelia 
(1) ↑ 
(2) ↓ 
(3) ↓ 
(1) ↓ 
(2) ↓ 
(3) ↓ 
 
“Compliant” 
 3D collagenc: 
(1) = 
(2) = 
(3) ↑ 
“Stiff”  
3D collagen d: 
(1) ↓ 
(2) ↓ 
(3) ↑ 
 
“Compliant” 3D 
collagenc: 
(1) = 
(2) = 
(3) ↓ 
“Stiff”  
3D collagen d: 
(1) ↓ 
(2) ↓ 
(3) ↓ 
Metastasis 
progression 
series:57 
(1) 67NR - 
tumorigenic 
(2) 168FARN – 
micrometastases 
(3) 4T07 – 
secondary 
micrometastases 
(4) 66c14 – 
NmuMg 
mouse  
breast 
epithelial  
line  
↓ 
(relative  
to 
67NR) 
↓ 
(relative  
to 
NmuMG) 
Collagen gel: 
↑ 
(relative to  
67NR) 
Collagen gel: 
66c14  
↓ 
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Table 1: Studies reporting cell speed and persistence in 3D cultures compared with 2D 
migration parameters in the same cell background.  
areduced focal adhesion length and increased rates of focal adhesion turnover, bincreased rates of 
focal adhesion disassembly, celastic modulus = 103Pa, delastic modulus = 391Pa, eeffects were 
compared across a range of collagen concentrations (2, 3 and 4 mg/mL), fmeasured dynamics of 
GFP-tagged talin adhesions in CDM and showed multiple roles – paxillin depletion caused 
increased numbers of highly dynamic, peripheral, short-lived adhesions, increased stability of 
more centrally located adhesions accompanied by reduced rates of adhesion assembly and 
disassembly. #Cell derived matrix, ND not determined, = no change. Red arrows indicate 
examples in increased speed or persistence in 3D. 
  
secondary 
tumours 
Paxillin 
siRNA(f)94 
MDA-MB-
231  
breast cancer 
ND ND 
CDM# 
↓ ↓ 
Hic-5 siRNA94 
MDA-MB-
231  
breast cancer 
ND ND 
CDM# 
↓ ↓ 
High α5β162 
MDA-MB-
231  
breast cancer 
ND ND 
3D collagen 
↑ 
 
↑ 
 26
Adhesion  
molecule 
 
in vivo Model 
 
Metastasis Phenotype 
 
 
 
 
 
 
 
FAK 
 
 
Intravenous injection 
of FAK-/- tumour 
cells.82 
Failed to form lung tumours; cells retained in the 
lung capillary bed were rounded and lacked 
membrane extensions into the vessel. 
Activated ErbB2 
mammary tumour 
model with epithelial-
specific FAK 
deletion.69 
Metastatic lung tumours all negative for cells with 
homozygous deletion of FAK. 
Mammary epithelium-
specific deletion of 
FAK in MMTV-
PyVmT Mouse Tumor 
Model.70 
Metastatic lung tumours all negative for cells with 
homozygous deletion of FAK. 
Mammary epithelium-
specific deletion of 
FAK in MMTV-
PyVmT Mouse Tumor 
Model.71 
Reduced lung tumour metastases. 
Orthotopic injection of 
pancreatic cancer cells 
treated with FAK 
siRNA.73 
Prevented formation of liver metastases. 
p130Cas 
Mammary tumour 
model – injection of 
cells expressing 
inducible p130Cas 
shRNA.77 
Inhibits lung colonisation. 
Athymic nude mice 
injected sub-
cutaneously with 
p130Cas-/- fibroblasts 
transformed with 
oncogenic Src and 
expressing p130Cas.78  
Exogenous p130Cas expression increased 
formation of metastatic lung tumours after surgical 
removal of primary tumours; authors comment that 
“the capacity of the cells to invade through 
Matrigel was strongly correlated with their 
capacity to invade and metastasize in vivo.” 
Vinculin 
Exogenous vinculin 
expression in highly 
metastatic rat 
adenocarcinoma 
injected into foot pad.80 
Highest levels of vinculin expression suppressed 
formation of lung metastases, low to moderate 
expressors formed tumours in lymph nodes close 
to injection site but failed to form lung metastases. 
NEDD9 
Mammary epithelium-
specific deletion of 
NEDD9 in MMTV-
PyVmT Mouse Tumor 
Model.67 
Trend to fewer lung metastases. 
Tail vein injection of 
NEDD9-null primary 
tumours.8 
Tumours formed of null-cell lines exhibited 
increased aggressiveness, with all injected mice 
generating secondary tumours. 
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Talin 
Tail vein injections of 
prostate cancer cell 
lines treated with talin 
shRNA.84 
Reduced numbers of metastatic lung lesions. 
αvβ3 
 
Orthotopic injection 
into mammary fat pad 
with mammary 
carcinoma cell line 
expressing exogenous 
β3.76 
Drove unique formation of bone metastases; 
authors show increased haptotactic and 
chemotactic response to bone-matrix proteins and 
soluble factors. 
MDA-MB-435 breast 
cancer cells expressing 
constitutively active 
αvβ3 injected into 
mouse tail vein.81 
Enhanced lung colonization. 
Intravenous injection of 
metastatic αvβ3 
negative melanoma 
cells expressing 
exogenous β3.91 
Re-expression of β3 in metastatic, β3 negative 
lines reduced lung colonization. 
 
 
 
β1 integrin 
 
 
 
 
Conditional deletion of 
β1 integrin from 
mammary epithelia, 
crossed with 
MMTV/activated 
erbB2.72 
Significantly reduced formation of lung 
metastases. 
Orthotopic injection of 
pancreatic cancer cells 
treated with β1 integrin 
siRNA.74 
Absence of any metastatic tumours; controls 
treated with α2 or α3 integrin subunit siRNA 
displayed metastatic tumours. 
Conditional deletion of 
β1 integrin from 
pancreatic β cells 
crossed with Rip1Tag2 
mice.68 
Loss of β1 expression induced increased tumour 
cell emboli in the lymphatic vasculature but no 
metastasis formation; similarly, tail vein injections 
of β tumour cells lacking β1 integrin expression 
did not form metastases. 
Ras-myc transformed 
β1 null ES cells 
injected sub-
cutaneously.79 
Reduced numbers and size of metastatic foci in the 
lung. 
α5β1 
integrin 
 
HT-29 colon cancer 
cells expressing 
exogenous α5 integrin 
injected 
intravenously.85 
Significantly reduced lung and extrapulmonary 
metastases. 
Lewis Lung Carcinoma 
cells expressing α5 
shRNA injected into 
tail vein.83 
Fewer lung tumours. 
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Table 2. Summary of in vivo metastasis data, targeting the adhesion molecules 
described in Table 1. 
 
